These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17710547)

  • 1. Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.
    Ackerman Z; Oron-Herman M; Rosenthal T; Pappo O; Link G; Sela BA; Grozovski M
    Dig Dis Sci; 2008 Mar; 53(3):777-84. PubMed ID: 17710547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
    Ackerman Z; Oron-Herman M; Grozovski M; Rosenthal T; Pappo O; Link G; Sela BA
    Hypertension; 2005 May; 45(5):1012-8. PubMed ID: 15824194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liver.
    Ackerman Z; Grozovski M; Oron-Herman M; Rosenthal T; Sela BA; Amir G
    Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):37-42. PubMed ID: 23489555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease.
    Ackerman Z; Skarzinski G; Grozovski M; Oron-Herman M; Sela BA
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):545-51. PubMed ID: 24975050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk reduction therapy for syndrome X: comparison of several treatments.
    Oron-Herman M; Sela BA; Rosenthal T
    Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
    Ackerman Z; Oron-Herman M; Pappo O; Peleg E; Safadi R; Schmilovitz-Weiss H; Grozovski M
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):663-8. PubMed ID: 20210788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats.
    Prabhakar P; Reeta KH; Maulik SK; Dinda AK; Gupta YK
    Appl Physiol Nutr Metab; 2017 Jan; 42(1):23-32. PubMed ID: 27911087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.
    Schmilovitz-Weiss H; Hochhauser E; Cohen M; Chepurko Y; Yitzhaki S; Grossman E; Leibowitz A; Ackerman Z; Ben-Ari Z
    Lipids Health Dis; 2013 Mar; 12():41. PubMed ID: 23531105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine and glutathione cycle in hypercholesterolaemia.
    Mutaf I; Habif S; Turgan N; Parildar Z; Ozmen D; Bayindir O; Uysal A
    Acta Cardiol; 2004 Oct; 59(5):485-92. PubMed ID: 15529551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Ganoderma lucidum polysaccharides on oxidative stress of hyperlipidemic fatty liver in rats].
    Chang SS; Zhou D; Meng GL; Wu F; Wang S; Chen X; Xu JL
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3102-6. PubMed ID: 23311162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscoreophyllum cumminsii (Stapf) Diels leaves halt high-fructose induced metabolic syndrome: Hyperglycemia, insulin resistance, inflammation and oxidative stress.
    Ajiboye TO; Aliyu H; Tanimu MA; Muhammad RM; Ibitoye OB
    J Ethnopharmacol; 2016 Nov; 192():471-479. PubMed ID: 27568876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
    Bagul PK; Middela H; Matapally S; Padiya R; Bastia T; Madhusudana K; Reddy BR; Chakravarty S; Banerjee SK
    Pharmacol Res; 2012 Sep; 66(3):260-8. PubMed ID: 22627169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hibiscus sabdariffa calyx palliates insulin resistance, hyperglycemia, dyslipidemia and oxidative rout in fructose-induced metabolic syndrome rats.
    Ajiboye TO; Raji HO; Adeleye AO; Adigun NS; Giwa OB; Ojewuyi OB; Oladiji AT
    J Sci Food Agric; 2016 Mar; 96(5):1522-31. PubMed ID: 25965053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril on the cysteamine-induced duodenal ulcer in the rat.
    Saghaei F; Karimi I; Jouyban A; Samini M
    Exp Toxicol Pathol; 2012 May; 64(4):373-7. PubMed ID: 21036019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allylmercaptocaptopril: a new antihypertensive drug.
    Miron T; Rabinkov A; Peleg E; Rosenthal T; Mirelman D; Wilchek M
    Am J Hypertens; 2004 Jan; 17(1):71-3. PubMed ID: 14700516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f. (Apocynaceae) palliates hyperglycemia, insulin resistance, dyslipidemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome in rats.
    Ajiboye TO; Hussaini AA; Nafiu BY; Ibitoye OB
    J Ethnopharmacol; 2017 Feb; 198():184-193. PubMed ID: 27894971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic and hepatoprotective effects of D-chiro-inositol-enriched tartary buckwheat extract in high fructose-fed mice.
    Hu Y; Zhao Y; Ren D; Guo J; Luo Y; Yang X
    Food Funct; 2015 Dec; 6(12):3760-9. PubMed ID: 26412138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
    Si X; Webb RC; Richey JM
    Can J Physiol Pharmacol; 1999 Oct; 77(10):755-62. PubMed ID: 10588479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine attenuates oxidative stress-induced hypertension.
    Ganafa AA; Walton M; Eatman D; Abukhalaf IK; Bayorh MA
    Am J Hypertens; 2004 Sep; 17(9):743-8. PubMed ID: 15363814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.